Tumor-Intrinsic Galectin-3 Suppresses Melanoma Metastasis Article

Mohammed, NBB, Lau, LS, Souchak, J et al. (2024). Tumor-Intrinsic Galectin-3 Suppresses Melanoma Metastasis . JOURNAL OF INVESTIGATIVE DERMATOLOGY, 10.1016/j.jid.2024.02.011

cited authors

  • Mohammed, NBB; Lau, LS; Souchak, J; Qiu, S; Ahluwalia, MS; Osman, I; Dimitroff, CJ


  • Melanoma poses a poor prognosis with high mortality rates upon metastasis. Exploring the molecular mechanisms governing melanoma progression paves the way for developing novel approaches to control melanoma metastasis and ultimately enhance patient survival rates. Extracellular galectin-3 (Gal-3) has emerged as a pleiotropic promoter of melanoma metastasis, exerting varying activities depending on its interacting partner. However, whether intracellular Gal-3 promotes melanoma aggressive behavior remains unknown. In this study, we explored Gal-3 expression in human melanoma tissues as well as in murine melanoma models to examine its causal role in metastatic behavior. We found that Gal-3 expression is downregulated in metastatic melanoma tissues compared with its levels in primary melanomas. Enforced silencing of Gal-3 in melanoma cells promoted migration, invasion, colony formation, in vivo xenograft growth, and metastasis and activated canonical oncogenic signaling pathways. Moreover, loss of Gal-3 in melanoma cells resulted in upregulated the expression of the prometastatic transcription factor NFAT1 and its downstream metastasis-associated proteins, matrix metalloproteinase 3, and IL-8. Overall, our findings implicate melanoma intracellular Gal-3 as a major determinant of its metastatic behavior and reveal a negative regulatory role for Gal-3 on the expression of NFAT1 in melanoma cells.

publication date

  • January 1, 2024

published in

Digital Object Identifier (DOI)